Effects of a mycophenolate mofetil-based immunosuppressive regimen in Chagas' heart transplant recipients [2]

Transplantation

Volumn 84, Issue 3, 2007, Pages 441-442

  Bestetti, Reinaldo B ^a   Souza, Tatiana R ^a   Lima, Milena F ^a   Theodoropoulos, Tatiana A D ^a   Cordeiro, José A ^b   Burdmann, Emmanuel A ^a  

^a HOSPITAL DE BASE   (Brazil)

^b FACULDADE DE MEDICINA DE SÃO JOSÉ DO RIO PRETO   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

BENZNIDAZOLE; CALCINEURIN INHIBITOR; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISONE;

CHAGAS DISEASE; GRAFT RECIPIENT; HEART FAILURE; HEART TRANSPLANTATION; HUMAN; IMMUNOFLUORESCENCE TEST; IMMUNOSUPPRESSIVE TREATMENT; LETTER; PRIORITY JOURNAL; TRYPANOSOMA CRUZI;

ANIMALS; CHAGAS CARDIOMYOPATHY; CHAGAS DISEASE; GRAFT REJECTION; HEART; HEART TRANSPLANTATION; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MYCOPHENOLIC ACID; TRYPANOSOMA CRUZI;

EID: 34547893831     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.tp.0000277526.68754.02     Document Type: Letter

References (6)

1. Kobashigawa J, Meiser BM. Review of major clinical trials with mycophenolate mofetil in cardiac transplantation. Transplantation 2005; 80(Suppl 2S): S235.
2. Bocchi EA, Fiorelli A. The paradox of survival results after heart transplantation for cardiomyopathy caused by Trypanosoma cruzi. Ann Thorac Surg 2001; 71: 1833.
3. Bestetti RB, Muccillo G. Clinical course of Chagas' heart disease: A comparison with dilated cardiomyopathy. Int J Cardiol 1997; 60: 187.
4. Billingham ME, Cary NA, Hammond ME, et al. A working formulation for the standartization nomenclature in the diagnosis of heart and lung rejection: Heart Rejection Study Group. J Heart Lung Transplant 1990; 9: 587.
5. Bacal F, Silva CP, Bocchi EA, et al. Mycophenolate mofetil increased Chagas' disease reactivation in heart transplanted patients: comparison between two different protocols. Am J Transplant 2006; 5: 2017.
6. van Gelden T, Le Meur Y, Shaw LM, et al. Therapeutic drug monitoring for mycophenolate mofetile in transplantation. Ther Drug Monit 2006; 28: 145.